These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19619503)

  • 1. The enigmatic role of tafazzin in cardiolipin metabolism.
    Houtkooper RH; Turkenburg M; Poll-The BT; Karall D; Pérez-Cerdá C; Morrone A; Malvagia S; Wanders RJ; Kulik W; Vaz FM
    Biochim Biophys Acta; 2009 Oct; 1788(10):2003-14. PubMed ID: 19619503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
    Ye C; Shen Z; Greenberg ML
    J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin-deficient cells.
    Oemer G; Koch J; Wohlfarter Y; Lackner K; Gebert REM; Geley S; Zschocke J; Keller MA
    J Inherit Metab Dis; 2022 Jan; 45(1):38-50. PubMed ID: 34494285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome.
    Petit PX; Ardilla-Osorio H; Penalvia L; Rainey NE
    Cells; 2020 Oct; 9(10):. PubMed ID: 33096711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome.
    Zhang J; Liu X; Nie J; Shi Y
    Autophagy; 2022 Sep; 18(9):2134-2149. PubMed ID: 34985382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barth syndrome, a human disorder of cardiolipin metabolism.
    Schlame M; Ren M
    FEBS Lett; 2006 Oct; 580(23):5450-5. PubMed ID: 16973164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
    Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
    Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
    Ikon N; Ryan RO
    Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
    Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
    Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Drosophila model of Barth syndrome.
    Xu Y; Condell M; Plesken H; Edelman-Novemsky I; Ma J; Ren M; Schlame M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11584-8. PubMed ID: 16855048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiolipin function in the yeast S. cerevisiae and the lessons learned for Barth syndrome.
    Ji J; Greenberg ML
    J Inherit Metab Dis; 2022 Jan; 45(1):60-71. PubMed ID: 34626131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia.
    Chowdhury A; Aich A; Jain G; Wozny K; Lüchtenborg C; Hartmann M; Bernhard O; Balleiniger M; Alfar EA; Zieseniss A; Toischer K; Guan K; Rizzoli SO; Brügger B; Fischer A; Katschinski DM; Rehling P; Dudek J
    Cell Rep; 2018 Oct; 25(3):561-570.e6. PubMed ID: 30332638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
    Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
    J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.
    Houtkooper RH; Rodenburg RJ; Thiels C; van Lenthe H; Stet F; Poll-The BT; Stone JE; Steward CG; Wanders RJ; Smeitink J; Kulik W; Vaz FM
    Anal Biochem; 2009 Apr; 387(2):230-7. PubMed ID: 19454236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase.
    Schlame M; Xu Y
    J Mol Biol; 2020 Aug; 432(18):5043-5051. PubMed ID: 32234310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
    Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tafazzin-dependent cardiolipin composition in C6 glioma cells correlates with changes in mitochondrial and cellular functions, and cellular proliferation.
    Gürtler S; Wolke C; Otto O; Heise N; Scholz F; Laporte A; Elsner M; Jörns A; Weinert S; Döring M; Jansing S; Gardemann A; Lendeckel U; Schild L
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Apr; 1864(4):452-465. PubMed ID: 30639735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.